GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » EV-to-Revenue

Whanin Pharm Co (XKRX:016580) EV-to-Revenue : 0.67 (As of May. 25, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Whanin Pharm Co's enterprise value is ₩157,813 Mil. Whanin Pharm Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩236,463 Mil. Therefore, Whanin Pharm Co's EV-to-Revenue for today is 0.67.

The historical rank and industry rank for Whanin Pharm Co's EV-to-Revenue or its related term are showing as below:

XKRX:016580' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.38   Med: 1.09   Max: 2.84
Current: 0.67

During the past 13 years, the highest EV-to-Revenue of Whanin Pharm Co was 2.84. The lowest was 0.38. And the median was 1.09.

XKRX:016580's EV-to-Revenue is ranked better than
87.6% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs XKRX:016580: 0.67

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Whanin Pharm Co's stock price is ₩15050.00. Whanin Pharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩15,485.72. Therefore, Whanin Pharm Co's PS Ratio for today is 0.97.


Whanin Pharm Co EV-to-Revenue Historical Data

The historical data trend for Whanin Pharm Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co EV-to-Revenue Chart

Whanin Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.79 0.82 0.72 0.92 0.66

Whanin Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.68 0.62 0.66 0.63

Competitive Comparison of Whanin Pharm Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Whanin Pharm Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's EV-to-Revenue falls into.



Whanin Pharm Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Whanin Pharm Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=157812.950/236463.335
=0.67

Whanin Pharm Co's current Enterprise Value is ₩157,813 Mil.
Whanin Pharm Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩236,463 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Whanin Pharm Co  (XKRX:016580) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Whanin Pharm Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=15050.00/15485.718
=0.97

Whanin Pharm Co's share price for today is ₩15050.00.
Whanin Pharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩15,485.72.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Whanin Pharm Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Whanin Pharm Co (XKRX:016580) Business Description

Traded in Other Exchanges
N/A
Address
84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co (XKRX:016580) Headlines

No Headlines